• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards | Inspections
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
 
Trade NameCOBAS INTEGRA 400 PLUS CYCLOSPORINE
Classification Namecyclosporine
Regulation Number862.1235
ApplicantDADE BEHRING, INC.
PMA NumberP920031
Supplement NumberS003
Date Received05/17/2002
Decision Date07/24/2002
Product Code
MKW[ Registered Establishments with MKW ]
Advisory Committee Toxicology
Supplement Typenormal 180 day track
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for expanding the use of the cobas integra cyclosporine reagent to the cobas integra 400 plus analyzer. The device, as modified, will be marketed under the trade name cobas integra cyclosporine and is indicated for quantitative determination of cyclosporine in whole blood as an aid in the management of cyclosporine therapy in kidney, heart and liver transplant patients.
-
-